Influenza A virus A/Brisbane/10/2010 (H1N1) antigen (MDCK cell derived, propiolactone inactivated) Recruiting Phase 4 Trials for Flu caused by Influenza Basic Science

Back to Influenza A virus A/Brisbane/10/2010 (H1N1) antigen (MDCK cell derived, propiolactone inactivated)

Indications	Status	Purpose	Phase
DBCOND0021701 (Flu caused by Influenza)	Recruiting	Basic Science	4

clinicaltrials.gov Identifier	Title	Drugs
NCT04101838	B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults	Influenza A virus A/Brisbane/10/2010 (H1N1) antigen (MDCK cell derived, propiolactone inactivated) (DB10998) Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated) (DB10791) Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (formaldehyde inactivated) (DB14455) Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) antigen (formaldehyde inactivated) (DB10792) Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (MDCK cell derived, propiolactone inactivated) (DB10999) Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) (DB14445) Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) (DB10794) Influenza B virus B/Brisbane/9/2014 antigen (formaldehyde inactivated) (DB14456) Influenza B virus B/Massachusetts/2/2012 antigen (MDCK cell derived, propiolactone inactivated) (DB11000)